Positioning Statement
Latest News

BIO Ventures for Global Health

BIO Ventures for Global Health (BVGH) is a results-oriented nonprofit organization based in Seattle, Washington. BVGH was established in 2004 by the Biotechnology Innovation Organization (BIO) to engage biotechnology, pharmaceutical, and diagnostic companies in meaningful initiatives and programs to impact global health. BVGH programs fall within three categories:

  • R&D for poverty-related diseases
  • Capacity building in low- and middle-income countries
  • Access to medicines

For more information about BVGH, services offered, or current programs download the brochure.

BVGH President co-authors a letter to the editor of JAMA in response to PRV article

BIO Ventures for Global Health (BVGH) President, Jennifer Dent, co-authored a letter to the editor of JAMA highlighting the efficacy of the priority review voucher (PRV) program in spurring drug development for neglected tropical diseases. The editorial, “Efficacy of the Priority Review Voucher Program”, outlines the critical role PRVs play by offering a financial incentive that complements existing drug development mechanisms to stimulate drug innovation and investment. Click here to learn more.

WHO Proposes New Approach for Funding and Managing Health Product R&D

The Special Programme for Research and Training in Tropical Diseases (TDR) at the World Health Organization (WHO) recently published, Health Product Research and Development Fund: a Proposal for Financing and Operation, which describes how a potential pooled fund could operate under the governance of WHO Member States. It also provides new financial modelling tools and mechanisms to guide the fund’s operation. Click here to learn more and to read the entire report.

BVGH Calls for More Collaboration between Industry and Governments to Increase Access to Medicines

Jennifer Dent, President of BIO Ventures for Global Health (BVGH) called for the expansion and scale-up of collaborations between the biopharmaceutical industry, researchers, and governments to facilitate greater access to medicines during a United Nations panel. Click here to read more. 

Merck & Co., Inc. publishes case study highlighting importance of collaboration in advancing healthcare in Africa

Merck & Co., Inc. recently published a case study highlighting fellowships BIO Ventures for Global Health (BVGH) organized and facilitated for two sets of Richard T. Clark fellows over the past two years. The fellows traveled to Africa where they worked with local universities to determine research interests, capabilities, needs and, ultimately, to identify BVGH program and partnership opportunities. Click here to read more. 

BVGH releases 2015 Partnership Hub Report summarizing WIPO Re:Search achievements

BIO Ventures for Global Health (BVGH) released the 2015 Partnership Hub Report today. The report summarizes partnering and communications objectives and achievements from the past year and highlights new members and member feedback. Click here to read more.